WANA (Jul 13) – In the world of medicine, the difference between life and death often hinges on the precision of a diagnosis. This is especially true for pediatric cancers, where early detection can dramatically change a patient’s outcome. Among the most challenging of these is adrenal (neuroblastoma) cancer in children under five—an aggressive disease that often progresses silently and is hard to detect at early stages.

 

Against this backdrop, Iran’s successful development and local production of the Iodine-123 (I-123) radiopharmaceutical mark a significant milestone in advancing the country’s medical capabilities. This radiopharmaceutical enables highly precise imaging, helping doctors locate and diagnose tumors at their earliest stages. I-123 is particularly effective in detecting neuroblastoma because it mimics the behavior of neuroblastic cells, selectively binding to the sites where these cancer cells have spread or metastasized in the body.

 

One of the key advantages of I-123 over older alternatives like I-131 MIBG is its shorter half-life—about 13 hours—which translates to greater safety for young patients. However, this short half-life also makes importing the isotope impractical, meaning local production was the only viable path to ensure patient access. Iranian nuclear medicine experts overcame this barrier by fully indigenizing the technology, making this critical diagnostic tool available to hospitals nationwide.

 

This achievement adds to a growing portfolio of more than 70 types of diagnostic, therapeutic, and palliative radiopharmaceuticals now produced in Iran. It is a clear demonstration of how peaceful nuclear technology can serve public health, even in the face of sanctions, threats, and technological restrictions.

 

Experts note that bringing Iodine-123 into clinical use will help doctors detect hard-to-treat cancers much earlier, improve treatment outcomes, extend patient survival, and enhance quality of life—especially for young children. Beyond being a scientific and technological success, this development stands as a testament to the determination of Iranian specialists to harness nuclear technology for saving lives and promoting health.